Rebecca Gilbert, MD, Ph.D., Author at American Parkinson Disease Association

How People with Parkinson’s Disease Can Minimize Risks During Hospitalization

Posted on August 5, 2025August 13, 2025 by Rebecca Gilbert, MD, Ph.D.

Hospitalization can be stressful and challenging for anyone, but for people living with Parkinson’s disease (PD), a hospital stay...see more can present unique risks. It is important for patients and their loved ones to be prepared for these situations in order to mitigate issues that may arise and have a chance at the best possible outcome. […]

Adaptive Deep Brain Stimulation: A New Era in Parkinson’s Disease Treatment

Posted on July 22, 2025July 22, 2025 by Rebecca Gilbert, MD, Ph.D.

How Adaptive DBS Aims to Offer More Personalized and Effective Therapy When the Food and Drug Administration (FDA) approved...see more deep brain stimulation (DBS) for Parkinson’s disease (PD) in 2002, it revolutionized the PD treatment landscape. DBS has since become a very effective therapy for certain patients whose symptoms are no longer adequately controlled by medication […]

Nanocarrier Breakthrough Offers Hope for Parkinson’s Disease Treatment

Posted on July 9, 2025July 9, 2025 by Rebecca Gilbert, MD, Ph.D.

How Nanocarriers Overcome a Major Hurdle in Parkinson’s Treatment Delivering medications to the brain is one of the most...see more significant challenges in modern medicine. The brain is protected by an incredibly selective shield known as the blood-brain barrier (BBB), a defense mechanism that keeps out toxins and harmful agents but also prevents many therapeutic drugs […]

Exploring Non-Invasive Neuromodulation for Parkinson’s Disease

Posted on June 24, 2025June 23, 2025 by Rebecca Gilbert, MD, Ph.D.

What is neuromodulation and how can it be used to treat Parkinson’s disease? Medication remains the primary method of...see more treating Parkinson’s disease (PD). However, neuromodulation, or therapies that involve the manipulation of brain circuitry, can also be very effective in controlling PD symptoms in particular clinical situations. Two current neuromodulatory techniques for PD are deep […]

Parkinson’s Disease Research Insights from Dr. J. Timothy Greenamyre

Posted on June 10, 2025June 25, 2025 by Rebecca Gilbert, MD, Ph.D.

Shaping the Future of Parkinson’s Treatment: Dr. Greenamyre’s Contributions and Outlook The American Parkinson Disease Association (APDA) is committed...see more to furthering Parkinson’s disease (PD) research and proudly invests in the most promising clinicians and scientific projects focused on the discovery of the cause(s) and finding the cure(s) for PD. Our Centers for Advanced Research, along with […]

How AI is Revolutionizing Parkinson’s Research and Clinical Care

Posted on May 29, 2025May 29, 2025 by Rebecca Gilbert, MD, Ph.D.

Understanding AI: A Powerful Tool in the Fight Against Parkinson’s Disease Artificial Intelligence (AI) is all around us and...see more becoming more and more ubiquitous in many aspects of our lives, including Parkinson’s disease (PD) research and clinical care. But what exactly is AI, and how is it accelerating PD research and improving how doctors care […]

New Parkinson’s Disease Treatments in the Clinical Trial Pipeline

Posted on May 14, 2025May 14, 2025 by Rebecca Gilbert, MD, Ph.D.

Promising New Treatments for Parkinson’s: What’s in the Clinical Trial Pipeline? There remains an urgent unmet need for Parkinson’s...see more disease (PD) treatments that slow or halt the underlying neurodegenerative process that leads to disease progression. Much research is focused on this, with clinical trials underway. It is also critical that medications continue to be developed […]

Understanding the Different Forms of Carbidopa/Levodopa: Additional Questions Answered

Posted on April 29, 2025May 14, 2025 by Rebecca Gilbert, MD, Ph.D.

Exploring the New Forms of Carbidopa/Levodopa with Dr. Vaou On a recent episode of APDA’s Dr. Gilbert Hosts, I spoke with...see more Dr. Okeanis Vaou, a movement disorders specialist, about the various new formulations of carbidopa/levodopa that are available, including Crexont® and Vyalev®, among others. Carbidopa/levodopa is the mainstay of treatment for Parkinson’s disease (PD) and is […]

The History of the American Parkinson Disease Association

Posted on April 11, 2025April 17, 2025 by Rebecca Gilbert, MD, Ph.D.

The American Parkinson Disease Association (APDA) has long been committed to providing the support, education, research, and community that...see more helps everyone impacted by Parkinson’s disease (PD) live life to the fullest – a legacy that dates back to APDA’s founding in 1961, when a young woman named Sophia Esposito Maestrone sought to honor the memory […]